AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 38 filers reported holding AQUINOX PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $173,972 | -12.4% | 73,717 | 0.0% | 0.05% | -15.5% |
Q1 2019 | $198,667 | +24.8% | 73,717 | 0.0% | 0.06% | -32.6% |
Q4 2018 | $159,229 | -64.6% | 73,717 | +130.5% | 0.09% | -58.9% |
Q1 2018 | $450,377 | +91.5% | 31,987 | +59.9% | 0.21% | +54.8% |
Q4 2017 | $235,200 | – | 20,000 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 877,753 | $14,492,000 | 5.61% |
RA Capital Management | 2,191,977 | $36,190,000 | 5.13% |
Opaleye Management Inc. | 310,000 | $5,118,000 | 3.02% |
EMORY UNIVERSITY | 143,691 | $2,372,000 | 2.34% |
Baker Brothers Advisors | 10,536,092 | $173,951,000 | 1.70% |
Ghost Tree Capital, LLC | 225,000 | $3,715,000 | 0.89% |
Cormorant Asset Management, LP | 151,838 | $2,507,000 | 0.34% |
Eventide Asset Management | 175,000 | $2,889,000 | 0.19% |
JGP Global Gestao de Recursos Ltda. | 11,380 | $188,000 | 0.10% |
Virtus ETF Advisers LLC | 16,347 | $270,000 | 0.08% |